1. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use 
George L. Bakris, MD, John M. Burkart, MD, Eric D. Weinhandl, PhD, MS, Peter A. McCullough, MD, MPH, Michael A. Kraus, MD 
American Journal of Kidney Diseases 
Volume 68, Issue 5, Pages S15-S23 (November 2016)
DOI: /j.ajkd
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Distribution of predialysis systolic blood pressure in the Dialysis Outcomes and Practice Patterns Study Practice Monitor, December
American Journal of Kidney Diseases  , S15-S23DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

3. Figure 2
Effects of intensive versus conventional hemodialysis on predialysis systolic blood pressure in the Frequent Hemodialysis Network (FHN) Daily Trial,42 FHN Nocturnal Trial,42 and Canadian trial of nocturnal hemodialysis.46 Estimated treatment effects (solid dots) and associated 95% confidence intervals (solid lines) are displayed at the bottom.
American Journal of Kidney Diseases  , S15-S23DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

4. Figure 3
Mean number of prescribed antihypertensive medications at baseline, month 4, and month 12 of the Frequent Hemodialysis Network (FHN) Daily Trial.42 Dashed bars span 1 standard deviation above and below the mean.
American Journal of Kidney Diseases  , S15-S23DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

5. Figure 4
Mean number of prescribed antihypertensive medications at baseline, month 4, and month 12 of the Frequent Hemodialysis Network (FHN) Nocturnal Trial.42 Dashed bars span 1 standard deviation above and below the mean.
American Journal of Kidney Diseases  , S15-S23DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions